Clinical Trials Logo

Filter by:
  • Not yet recruiting  
  • Page [1]
NCT ID: NCT03598751 Not yet recruiting - Psoriatic Arthritis Clinical Trials

BCD-085-8 (Anti-interleukin-17 Monoclonal Antibody) in Patients With Psoriatic Arthritis

Start date: July 25, 2018
Phase: Phase 3
Study type: Interventional

Study BCD-085-8/PATERA is a multicentre double-blind placebo-controlled Phase 3 study in patients with psoriatic arthritis (PsA). The objective of the study is to evaluate the efficacy and safety of BCD-085 comparing to placebo in patients with PsA.